title: 2010 World Stem Cell Summit--part 2. October 4-6, 2010, Detroit, MI, USA.
abstract: The 2010 World Stem Cell Summit, held in Detroit, included topics covering new developments in the field of regenerative medicine. This conference report highlights selected presentations on the cancer stem cell hypothesis, stem cell therapy for amyotrophic lateral sclerosis, GRNOPC-1 for spinal cord injury, the use of cord blood stem cells for spinal cord injury, mesenchymal stem cell research and applications in cardiac therapy, tissue engineering, and very small embryonic-like stem cells. Investigational drugs discussed include NSI-566RSC (Neuralstem) and GRNOPC-1 (Geron Corp).
authors.affiliation: London Business School, Regent's Park, London, NW1 4SA, UK. avertes.sln2004@london.edu
authors.forename: Alain
authors.initials: A
authors.lastname: Vertès
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000628:therapy; D000818:Animals; D006801:Humans; D009369:Neoplasms / Q000378:metabolism; D013119:Spinal Cord Injuries / Q000628:therapy; D033581:Stem Cell Transplantation / Q000639:trends*; D013234:Stem Cells / Q000378:metabolism; D023822:Tissue Engineering / Q000639:trends; D018754:Ventricular Dysfunction / Q000628:therapy